China's success in cleaning up air pollution may have accelerated global warming: Study
The decline in aerosol emissions — which can cool the planet by absorbing sunlight — have added about 0.05 degrees Celsius in warming per decade since 2010, according to the study, published on Monday in Communications Earth & Environment.
At that time, China began implementing aggressive air quality policies and was ultimately able to achieve a 75 percent reduction in emissions rate of toxic sulfur dioxide, the authors noted.
Sulfur dioxide gas, harmful pollutants that result from fossil fuel combustion and volcanoes, are precursors of sulfate aerosols, which are the dominant aerosol species that cool the Earth today.
Despite posing health threats to plants, humans and other animals, these particles are among the many types of aerosols that also cool the planet.
When clouds form around aerosols, such particles can absorb solar energy from the atmosphere and thereby reduce sunlight at ground level. And if clouds are not present, aerosols can reflect sunlight back into outer space.
Before China's air quality improvement policies took effect, pollution was a leading cause of premature death in the country, the study authors noted.
However, with fewer cooling aerosols now present in the atmosphere, areas of East Asia and around the world have endured intensified warming — and are expected to face even more extreme heat, shifting monsoon patterns and potential disruptions to agriculture, according to the study.
The plunge in sulfate levels 'partially unmasks greenhouse-gas driven warming and influences the spatial pattern of surface temperature change,' the researchers observed.
'Reducing air pollution has clear health benefits, but without also cutting CO₂, you're removing a layer of protection against climate change,' co-author Robert Allen, a climatology professor at the University of California, Riverside, said in statement.
'It highlights the need for parallel efforts to improve air quality and reduce greenhouse gas emissions,' he said.
Allen and his colleagues drew their conclusions based on simulations from major climate models for the years 2015 to 2049, using data from the Regional Aerosol Model Intercomparison Project, which includes contributions from the U.S., Europe and Asia.
They projected a global, annual mean warming of about 0.07 degrees Celsius due to aerosol emissions reductions, with 0.05 degrees Celsius of warming per decade already occurring since 2010.
Emissions reductions applied to their simulations corresponded closely with those realized over the 2010 to 2023 period in East Asia, the authors noted, adding that emissions from the region are expected to continue to decline — albeit at a slower rate.
Although their work focused on sulfate aerosols, the researchers stressed that carbon dioxide and methane emissions remain the biggest drivers of long-term climate change.
'Our study focused on the recent, dramatic speedup in global warming, which is very concerning but still small compared to the overall, long-term amount of warming from increased CO2 and methane,' said lead author Bjørn Samset, a senior researcher at the Center for International Climate and Environmental Research in Norway, in a statement.
Allen, meanwhile, also emphasized that because aerosols are short-lived in the atmosphere, the spike in global temperatures could subside in the near future.
'Sulfur dioxide and sulfate aerosols have lifetimes of about a week,' he said. 'Once they're removed, we'll eventually settle back into a warming rate that's more consistent with the long-term trend.'
As other regions across the world, including South Asia, Africa and North America, begin to phase out aerosol emissions, the scientists said they plan to analyze how potential shifts could shape forthcoming climate trends.
'Air quality improvements are a no-brainer for public health,' Allen said. 'But if we want to prevent the worst impacts of climate change, we have to cut CO₂ and methane too. The two must go hand in hand.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fast Company
27 minutes ago
- Fast Company
Why FEMA's flood maps often miss dangerous flash flood risks
Deadly and destructive flash flooding in Texas and several other states in July 2025 is raising questions about the nation's flood maps and their ability to ensure that communities and homeowners can prepare for rising risks. The same region of Texas Hill Country where a flash flood on July 4 killed more than 130 people was hit again with downpours a week later, forcing searchers to temporarily pause their efforts to find missing victims. Other states, including New Mexico, Oklahoma, Vermont, and Iowa, also saw flash flood damage in July. The U.S. Federal Emergency Management Agency's flood maps are intended to be the nation's primary tool for identifying flood risks. Originally developed in the 1970s to support the National Flood Insurance Program, these maps, known as Flood Insurance Rate Maps, or FIRMs, are used to determine where flood insurance is required for federally backed mortgages, to inform local building codes and land-use decisions, and to guide flood plain management strategies. In theory, the maps enable homeowners, businesses, and local officials to understand their flood risk and take appropriate steps to prepare and mitigate potential losses. But while FEMA has improved the accuracy and accessibility of the maps over time with better data, digital tools, and community input, the maps still don't capture everything—including the changing climate. There are areas of the country that flood, some regularly, that don't show up on the maps as at risk. I study flood-risk mapping as a university-based researcher and at First Street, an organization created to quantify and communicate climate risk. In a 2023 assessment using newly modeled flood zones with climate-adjusted precipitation records, we found that more than twice as many properties across the country were at risk of a 100-year flood than the FEMA maps identified. Even in places where the FEMA maps identified a flood risk, we found that the federal mapping process, its overreliance on historical data, and political influence over the updating of maps can lead to maps that don't fully represent an area's risk. What FEMA flood maps miss FEMA's maps are essential tools for identifying flood risks, but they have significant gaps that limit their effectiveness. One major limitation is that they don't consider flooding driven by intense bursts of rain. The maps primarily focus on river channels and coastal flooding, largely excluding the risk of flash flooding, particularly along smaller waterways such as streams, creeks, and tributaries. This limitation has become more important in recent years due to climate change. Rising global temperatures can result , leaving more areas vulnerable to flooding, yet unmapped by FEMA. For example, when flooding from Hurricane Helene hit unmapped areas around Asheville, North Carolina, in 2024, it caused a huge amount of uninsured damage to properties. Even in areas that are mapped, like the Camp Mystic site in Kerr County, Texas, that was hit by a deadly flash flood on July 4, 2025, the maps may underestimate their risk because of a reliance on historic data and outdated risk assessments. Political influence can fuel long delays Additionally, FEMA's mapping process is often shaped by political pressures. Local governments and developers sometimes fight high-risk designations to avoid insurance mandates or restrictions on development, leading to maps that may understate actual risks and leave residents unaware of their true exposure. An example is New York City's appeal of a 2015 FEMA Flood Insurance Rate Maps update. The delay in resolving the city's concerns has left it with maps that are roughly 20 years old, and the current mapping project is tied up in legal red tape. On average, it takes five to seven years to develop and implement a new FEMA Flood Insurance Rate Map. As a result, many maps across the U.S. are significantly out of date, often failing to reflect current land use, urban development, or evolving flood risks from extreme weather. This delay directly affects building codes and infrastructure planning, as local governments rely on these maps to guide construction standards, development approvals, and flood mitigation projects. Ultimately, outdated maps can lead to underestimating flood risks and allowing vulnerable structures to be built in areas that face growing flood threats. How technology advances can help New advances in satellite imaging, rainfall modeling, and high-resolution lidar, which is similar to radar but uses light, make it possible to create faster, more accurate flood maps that capture risks from extreme rainfall and flash flooding. However, fully integrating these tools requires significant federal investment. Congress controls FEMA's mapping budget and sets the legal framework for how maps are created. For years, updating the flood maps has been an unpopular topic among many publicly elected officials, because new flood designations can trigger stricter building codes, higher insurance costs, and development restrictions. In recent years, the rise of climate risk analytics models and private flood risk data have allowed the real estate, finance and insurance industries to rely less on FEMA's maps. These new models incorporate forward-looking climate data, including projections of extreme rainfall, sea-level rise and changing storm patterns—factors FEMA's maps generally exclude. Real estate portals like Zillow, Redfin, and now provide property-level flood risk scores that consider both historical flooding and future climate projections. The models they use identify risks for many properties that FEMA maps don't, highlighting hidden vulnerabilities in communities across the U.S. Research shows that the availability, and accessibility, of climate data on these sites has started driving property-buying decisions that increasingly take climate change into account. Implications for the future As homebuyers understand more about a property's flood risks, that may shift the desirability of some locations over time. Those shifts will have implications for property valuations, community tax-revenue assessments, population migration patterns, and a slew of other considerations. However, while these may feel like changes being brought on by new data, the risk was already there. What is changing is people's awareness. The federal government has an important role to play in ensuring that accurate risk assessments are available to individuals and communities everywhere. As better tools and models evolve for assessing risk evolve, FEMA's risk maps need to evolve, too.
Medscape
2 hours ago
- Medscape
How EU Price Cuts Are Fuelling a Global Drug Crisis
Experts warn that uncoordinated medicine price cuts across the EU are contributing to global drug shortages. In efforts to make healthcare systems more sustainable, many EU countries have independently reduced prices, putting pressure on manufacturers and prompting them to prioritise more profitable markets. This issue is the central focus of ongoing reforms of European pharmaceutical legislation, which is currently under debate. 'In Spain, these price cuts exceed the EU average, leading pharmaceutical companies to favour more profitable markets. Some medicines cost less than a piece of chewing gum, despite strict price regulations,' said Antoni Torres, M Pharm, president of the Federation of Associations of Pharmacy of Catalonia, Barcelona, Spain. In response to cost strain, many manufacturers have centralised production or relocated operations to countries with lower costs, increasing their vulnerability to supply chain disruptions. 'Most active pharmaceutical ingredients (APIs) used in Europe are produced in China and processed in India. As China's economy is growing, more of this manufacturing is being outsourced to other countries.' Torres said. This set-up creates vulnerabilities. If logistical problems arise, as seen during the pandemic, or if domestic demand increases in China, as it did after the end of the zero-COVID policy, shortages quickly ripple across the globe. According to a European Commission survey, over 50% of medicine shortages are caused by manufacturing disruptions, often linked to limited API supply chains. Local Constraints In Spain and Portugal, extremely low medicine prices and rules preventing pharmacists from substituting different formulations during shortages further widen supply gaps. However, changes in this regard are underway. In April, EU health ministers endorsed a draft revision of pharmaceutical and medical device legislation that allows member states to expand prescribing rights to nurses and physiotherapists and enables pharmacists to dispense approved therapeutic alternatives when the original medicine is unavailable. Sudden spikes in demand, such as those during the winter of 2022 with paediatric amoxicillin, contribute significantly to medicine shortages. Critical List To improve preparedness, the EC, European Medicines Agency (EMA), and national regulators published the first EU critical medicines list in 2023. The EMA's updated critical medicines list (2024) includes over 270 essential APIs used to treat infections, cardiovascular diseases, mental health disorders, and cancer. Most of these drugs are off patent, allowing broad manufacturing, but manufacturing is often dominated by just one or two suppliers. To reduce costs, many companies have outsourced manufacturing outside the EU, increasing their dependence on small groups of suppliers. Industry organisations such as Farmaindustria agree with this assessment, but caution should be exercised because procurement systems based solely on price could weaken local manufacturing and Europe's pharmaceutical autonomy. Farmaindustria argued that ensuring a stable supply requires incentives for investment, innovation, and sustainable industrial capacity in the EU. Current supply chains face several risks, such as sudden demand surges, manufacturing interruptions, quality control failures, and supplier withdrawals. New Legislation To address these issues, the EU introduced the Critical Medicines Act as part of its broader pharmaceutical reform. Legislation aims to strengthen drug availability across the pharmaceutical value chain, from quality control and manufacturing to competitiveness and accessibility. The EMA's newly expanded mandate includes monitoring, coordinating, and responding to drug shortages across the EU. According to the EC, the pharmaceutical sector employs approximately 800,000 people in the EU and is critical to both health systems and economic resilience in the region. Key goals include: Ensuring reliable access to essential medicines. Reducing reliance on single- or third-country suppliers. Addressing market failures that hinder equitable access across EU member states. Improving access to treatments for rare and high-priority conditions, especially in countries facing the most severe access challenges. 'Europe's plans to take measures to address medicine shortages is a major step in the right direction and confirms the correct direction and demands of the pharmaceutical sector. As a business, we hope these measures will ensure that patients have access to the medicines they need and contribute to more efficient and equitable healthcare in Europe, with pharmacies and pharmacists being the most effective means of achieving this due to their widespread availability and accessibility,' said Torres. Strategic Support As part of the pharmaceutical reform, the EU plans to support strategic projects to increase the production of essential medicines and their active ingredients. These projects will focus on creating, expanding, or upgrading manufacturing capacity and will benefit from incentives such as faster permits, simplified environmental assessments, technical assistance, and easier access to EU funding, particularly through the Strategic Technologies for Europe Platform. Public procurement will be used as a tool to strengthen supply chain security and encourage manufacturers to invest in Europe. Requirements such as source diversification and regular supply monitoring will apply. In situations where there is heavy reliance on imports, criteria favouring EU production could be prioritised. These measures can also be applied to other essential medicines. The reform also proposed a voluntary joint procurement system, allowing Member States to work with the European Commission to purchase essential medicines and others of shared interest. The mechanism offers three options: cross-border procurement between countries, commission-led procurement on behalf of Member States, and joint procurement with voluntary participation. All options were designed to respect the EU principles of subsidiarity and proportionality. With these measures, the EU aims to improve equitable and reliable access to essential medicines, thereby protecting public health during future supply crises. This story was translated from El Medico Interactivo.
New York Times
5 hours ago
- New York Times
China Is Spending Billions to Become an A.I. Superpower
When OpenAI blocked China's access to its advanced artificial intelligence systems last July, Chinese coders shrugged. They would rely instead on open-source systems, where the underlying technology is shared publicly for others to build on. At the time, that mostly meant turning to another popular American product made by Meta. But in the year since, there has been a major shift in the global race to develop advanced A.I. Chinese companies like DeepSeek and Alibaba have churned out open-source A.I. systems of their own that rank among the world's top performers. China is quickly closing the gap with the United States in the contest to make technologies that rival the human brain. This is not an accident. The Chinese government has spent a decade funneling resources toward becoming an A.I. superpower, using the same strategy it used to dominate the electric vehicle and solar power industries. 'China is applying state support across the entire A.I. tech stack, from chips and data centers down to energy,' said Kyle Chan, an adjunct researcher at the RAND Corporation, a think tank. For the past 10 years, Beijing has pushed Chinese companies to build manufacturing capabilities in high-tech industries for which the country previously depended on imports. That approach helped China become the maker of a third of the world's manufactured goods and a leader in electric vehicles, batteries and solar panels. And it has also been applied to the essential building blocks of advanced A.I. systems: computing power, skilled engineers and data resources. China pushed that industrial policy approach as three presidential administrations in Washington tried to hold back its ability to make technologies like artificial intelligence, including by restricting sales of chips made by Nvidia, America's leading A.I. chipmaker. Want all of The Times? Subscribe.
